Predict your next investment

Nivien Therapeutics company logo
HEALTHCARE | Biotechnology
nivientherapeutics.com

See what CB Insights has to offer

Founded Year

2017

Stage

Convertible Note | Alive

About Nivien Therapeutics

Nivien Therapeutics identifies and develops undervalued discoveries in the life sciences. The company's flagship program is an oncology platform. Nivien is a new platform to enhance IO-chemo combo therapies for treatment-resistant cancers by targeting the Hippo-YAP pathway.

Nivien Therapeutics Headquarter Location

125 Western Avenue

Boston, Massachusetts, 02163,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Nivien Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nivien Therapeutics is included in 1 Expert Collection, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

Nivien Therapeutics Patents

Nivien Therapeutics has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Human proteins
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/28/2019

Transcription factors, Human proteins, Proteins, Clusters of differentiation, Immunology

Application

Application Date

8/28/2019

Grant Date

Title

Related Topics

Transcription factors, Human proteins, Proteins, Clusters of differentiation, Immunology

Status

Application

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.